Guggenheim Capital’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $726K | Sell |
|
|||||
|
2025
Q1 | $762K | Buy |
|
|||||
|
2024
Q4 | $981K | Buy |
|
|||||
|
2024
Q3 | $600K | Buy |
|
|||||
|
2024
Q2 | $463K | Buy |
|
|||||
|
2024
Q1 | $405K | Buy |
|
|||||
|
2023
Q4 | $373K | Sell |
|
|||||
|
2023
Q3 | $1.18M | Buy |
|
|||||
|
2023
Q2 | $1.59M | Sell |
|
|||||
|
2023
Q1 | $1.3M | Sell |
|
|||||
|
2022
Q4 | $1.8M | Buy |
|
|||||
|
2022
Q3 | $1.55M | Sell |
|
|||||
|
2022
Q2 | $1.79M | Buy |
|
|||||
|
2022
Q1 | $1.75M | Buy |
|
|||||
|
2021
Q4 | $2.1M | Buy |
|